We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

373 hedge funds and large institutions have $9.87B invested in Jazz Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 121 increasing their positions, 146 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 30

9% more capital invested

Capital invested by funds: $9.08B → $9.87B (+$788M)

5% more funds holding

Funds holding: 354 → 373 (+19)

17% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 146

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

52% less call options, than puts

Call options by funds: $54M | Put options by funds: $113M

Holders
373
Holders Change
+19
Holders Change %
+5.37%
% of All Funds
10.05%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.35%
New
51
Increased
121
Reduced
146
Closed
30
Calls
$54M
Puts
$113M
Net Calls
-$59.1M
Net Calls Change
-$28.4M

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$272M
2
BIT
BlackRock Institutional Trust
California
+$261M
3
PC
PointState Capital
New York
+$76.6M
4
BG
BlackRock Group
United Kingdom
+$71.1M
5
NC
Nicholas Company
Wisconsin
+$60.4M

Top Sellers

1
Wells Fargo
Wells Fargo
California
-$68.1M
2
JHIU
Janus Henderson Investors US
Colorado
-$65.5M
3
HM
HealthCor Management
New York
-$56.2M
4
LPC
Lone Pine Capital
Connecticut
-$45.1M
5
Franklin Resources
Franklin Resources
California
-$27.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
MTIP
101
Magee Thomson Investment Partners
California
$10.6M -$4.88M -27,180 -31%
Allianz Asset Management
102
Allianz Asset Management
Germany
$10.4M +$2.68M +14,906 +34%
VCM
103
Vision Capital Management
Oregon
$10.2M -$2.95M -16,402 -22%
RAM
104
Riggs Asset Management
Pennsylvania
$10.2M -$177K -987 -2%
MAM
105
Martingale Asset Management
Massachusetts
$10.1M +$6.43M +35,804 +167%
BAMS
106
Bellevue Asset Management (Switzerland)
Switzerland
$9.86M -$449K -2,500 -4%
BCM
107
Brown Capital Management
Maryland
$9.81M -$852K -4,745 -8%
Korea Investment Corp
108
Korea Investment Corp
South Korea
$9.58M +$485K +2,700 +5%
BNP Paribas Asset Management
109
BNP Paribas Asset Management
France
$9.43M +$9.62M +53,561 New
ProShare Advisors
110
ProShare Advisors
Maryland
$9.18M +$18.3K +102 +0.2%
RhumbLine Advisers
111
RhumbLine Advisers
Massachusetts
$8.81M +$734K +4,087 +9%
RFC
112
Russell Frank Company
Washington
$8.81M +$1.32M +7,333 +17%
PCM
113
Palisade Capital Management
New Jersey
$8.68M -$4.22M -23,507 -32%
NFA
114
Nationwide Fund Advisors
Ohio
$8.62M -$5.74M -31,960 -40%
State of Wisconsin Investment Board
115
State of Wisconsin Investment Board
Wisconsin
$8.25M +$318K +1,770 +4%
FAM
116
Fred Alger Management
New York
$7.87M -$12.7M -70,450 -61%
GC
117
Guggenheim Capital
Illinois
$7.79M +$1.57M +8,755 +25%
BA
118
Boston Advisors
Massachusetts
$7.64M -$215K -1,195 -3%
BlackRock
119
BlackRock
New York
$7.5M +$7.65M +42,599 New
BIM
120
BlackRock Investment Management
Delaware
$7.47M +$7.62M +42,433 New
HSBC Holdings
121
HSBC Holdings
United Kingdom
$7.35M +$4.21M +23,426 +128%
AAM
122
Advisors Asset Management
Colorado
$7.23M +$819K +4,558 +12%
CAM
123
CG Asset Management
New York
$7.08M +$346K +1,925 +5%
CIBC Private Wealth Group
124
CIBC Private Wealth Group
Georgia
$7.08M -$9.16K -51 -0.1%
DekaBank Deutsche Girozentrale
125
DekaBank Deutsche Girozentrale
Germany
$6.78M +$156K +870 +2%
3 4
5
6 7

JAZZ Hedge Fund Activity: Q2 2015 in Review

373 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2015, worth a combined $9.87B — up 8.7% from $9.08B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new JAZZ positions and 30 closed out — a net gain of 21 holders — while 121 added to existing stakes and 146 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $272M. The largest seller was Wells Fargo, cutting an estimated $68.1M.

  • 373 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2015, up from 354 in Q1 2015.
  • Funds reported $9.87B of Jazz Pharmaceuticals stock for Q2 2015, up 8.7% quarter-over-quarter.
  • 51 funds opened new Jazz Pharmaceuticals positions in Q2 2015 and 30 closed out, a net change of +21 holders.
  • The largest Jazz Pharmaceuticals buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $272M added.
  • The largest Jazz Pharmaceuticals seller in Q2 2015 was Wells Fargo, an estimated $68.1M sold.

Based on aggregated 13F filings for Q2 2015.